Literature DB >> 19448643

Retrospective descriptive analysis of the physiological kinetics of prostate-specific antigen in men older than 75 years.

Maria Chiara Sighinolfi1, Salvatore Micali, Stefano De Stefani, Arrigo Cicero, Filippo Cianci, Marco Giacometti, Giampaolo Bianchi.   

Abstract

Several studies have compared prostate-specific antigen (PSA) kinetics in men with and without cancer, but there has been no adequate analysis of the longitudinal variation in PSA. The aim of this study was to assess the fluctuations in PSA in a cohort of elderly men in an attempt to define a physiological pattern of PSA kinetics. We searched a specific cohort of patients aged > 75 years and with PSA value < 2.0 ng mL(-1). A history of all PSA values over the past 10 years was compiled for each patient to create a database of patients fitting the following criteria: (1) minimum of five PSA measurements, (2) over at least 5 years. Exclusion criteria were: (1) PSA < 0.2 ng mL(-1) at each measurement and (2) having had more than one PSA test per year. In all, 1 327 patients (mean age: 78.52 years) fit the inclusion criteria. The mean variation from the first to the last PSA test was 0.05 +/- 0.43, with a mean follow-up of 6.79 +/- 1.71 years. Over the same period, the mean fluctuation from the lowest to the highest PSA value was 0.04 +/- 0.55 (P = 0.925). The mean annual PSA velocity (PSAV) was calculated by dividing the mean variation from the first to the last PSA test by the number of years of observation for each patient and was set at 0.0104 +/- 0.1050. Concluding, in a large-scale cohort of elderly individuals considered healthy and evaluated for a considerable follow-up, the average annual PSAV as well as the average fluctuation from the lowest to the highest PSA value are insignificant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448643      PMCID: PMC3735312          DOI: 10.1038/aja.2008.2

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  25 in total

1.  Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.

Authors:  K Ito; T Yamamoto; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka
Journal:  Urology       Date:  2000-08-01       Impact factor: 2.649

2.  Serum prostate-specific antigen and the biologic progression of prostate cancer.

Authors:  J N Kabalin; J E McNeal; I M Johnstone; T A Stamey
Journal:  Urology       Date:  1995-07       Impact factor: 2.649

3.  Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

Review 4.  Analysis of variation in prostate-specific antigen values.

Authors:  M Riehmann; P R Rhodes; T D Cook; G S Grose; R C Bruskewitz
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

5.  Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

Authors:  H B Carter; J D Pearson; E J Metter; L J Brant; D W Chan; R Andres; J L Fozard; P C Walsh
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

6.  Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Authors:  William J Catalona; Jerome P Richie; Frederick R Ahmann; M'Liss A Hudson; Peter T Scardino; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

7.  Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.

Authors:  H B Carter; J D Pearson; Z Waclawiw; E J Metter; D W Chan; H A Guess; P C Walsh
Journal:  Urology       Date:  1995-04       Impact factor: 2.649

8.  Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection.

Authors:  D S Smith; W J Catalona
Journal:  J Urol       Date:  1994-10       Impact factor: 7.450

Review 9.  Natural history of changes in prostate specific antigen in early stage prostate cancer.

Authors:  J D Pearson; H B Carter
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

10.  Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.

Authors:  David Ulmert; Angel M Cronin; Thomas Björk; Matthew F O'Brien; Peter T Scardino; James A Eastham; Charlotte Becker; Göran Berglund; Andrew J Vickers; Hans Lilja
Journal:  BMC Med       Date:  2008-02-15       Impact factor: 8.775

View more
  1 in total

1.  Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.

Authors:  Esther Walser-Domjan; Aline Richard; Monika Eichholzer; Elizabeth A Platz; Jakob Linseisen; Sabine Rohrmann
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.